Africa Press Release
Merck Foundation (Merck-Foundation.com) marks World Cancer Day together with Africa First Ladies and Ministries of Health through building cancer care capacity and increasing the limited number of oncologists in their countries by providing One-, two- and three-years fellowship, diploma and Master degree in oncology specialties for 90 African doctors from 25 Countries.
Merck Foundation makes history in Africa by training the first African oncologists and cancer care teams in countries such as The Gambia, Sierra Leone, Burundi, Liberia, Guinea Conakry, Central African Republic, Chad, Burundi, Malawi, Niger, Namibia, Zimbabwe and more.
Merck Foundation, the philanthropic arm of Merck KGaA Germany, marks ‘World Cancer Day 2022’ themed ‘Close the care gap’ together with African First Ladies through their Cancer Access Program to build cancer care capacity with the aim to increase the limited number of Oncologists and develop the first multidisciplinary cancer care teams across the continent.
Senator, Dr. Rasha Kelej, CEO of Merck Foundation, Most Influential African (2019, 2020&2021) emphasized, “We at Merck Foundation, together with African First Ladies, mark World Cancer Day every day, in a very special way and unique way. That is by transforming and advancing cancer care in Africa by building professional capacity and improving access to quality and equitable cancer care in the continent. We are making history together by providing this important training for the first oncologists and /or the first cancer care team in many countries across Africa”.
Despite rising incidence and mortality rates in Africa, cancer has been given low priority in the research field and healthcare services. It has been estimated that by 2030 there will be a 70% increase in new cancer cases due to population growth and aging.
“I am proud that Merck Foundation has successfully able to increase the limited number of Oncologist in Africa by providing Oncology specialty training to more than young 90 doctors from 25 African Countries”, Dr. Rasha Kelej added
Launched in 2016, the Merck Foundation Cancer Access Program provides One, two- and three-years fellowship, diploma and master degree for African doctors from 25 African countries. The clinical training is conducted in India, Egypt and Kenya. Moreover, Merck Foundation also recently started to provide scholarships for 2 years online PG Diploma in Cancer and Clinical Oncology from one of the reputed Universities of the UK.
“We are striving to form Multidisciplinary Oncology Care teams in many countries by providing training in Medical Oncology, Surgery Oncology, Pediatrics Oncology, Gynecology Oncology, Radiation Oncology, Oncology Nursing, Oncopathology, and Radiology Technician training. We are proud that we are making history in Africa through training the first oncologists and first cancer care teams in many countries such as; The Gambia, Sierra Leone, Burundi, Liberia, Guinea Conakry, Central African Republic, Chad, and Niger. Merck Foundation is committed to leading Africa to a better future through transforming the landscape of Cancer care in the continent”, explained Senator, Dr. Rasha Kelej.
The First Lady of The Gambia, H.E. Mrs. FATOUMATTA BAH-BARROW emphasized, “Merck Foundation is training the first-ever oncologists from our country. Having our own cancer specialists is very big for us and this has changed the cancer care sector in the country. I appreciate the efforts of Merck Foundation and deeply value our partnership with them”.
Merck Foundation through its Merck Foundation Cancer Access Program has till date provided training for 90 Oncologists from 25 countries which are: Botswana, Burundi, Cameroon, CAR, Chad, DRC, Ethiopia, Gabon, Gambia, Ghana, Guinee, Kenya, Lesotho, Liberia, Malawi, Mauritius, Namibia, Niger, Rwanda, Senegal, Sierra Leone, South Africa, Tanzania, Uganda, and Zambia.
To watch Senator, Dr. Rasha Kelej, CEO of Merck Foundation message of marking World Cancer Day 2022, please visit: https://bit.ly/34yvzvW
And to watch testimonials videos of Merck Foundation Oncology Fellowship Alumni, pls visit: https://bit.ly/34jmwiq
Distributed by APO Group on behalf of Merck Foundation.
Join the conversation on our social media platforms below and let your voice be heard:
Facebook: bit.ly/32YFKpv
Twitter: bit.ly/2TeOQNj
YouTube: bit.ly/3zc3up1
Instagram: bit.ly/3g6OYr3
Flicker: bit.ly/2Tay0Pu
Website: Merck-Foundation.com
Download the Merck Foundation App: bit.ly/3v7pf5Z
About Merck Foundation:
The Merck Foundation, established in 2017, is the philanthropic arm of Merck KGaA Germany, aims to improve the health and wellbeing of people and advance their lives through science and technology. Our efforts are primarily focused on improving access to quality&equitable healthcare solutions in underserved communities, building healthcare and scientific research capacity and empowering people in STEM (Science, Technology, Engineering, and Mathematics) with a special focus on women and youth. All Merck Foundation press releases are distributed by e-mail at the same time they become available on the Merck Foundation Website. Please visit www.merck-foundation.com to read more. To know more, reach out to our social media: Merck Foundation (Merck-Foundation.com); Facebook (https://bit.ly/32YFKpv), Twitter (https://bit.ly/2TeOQNj), Instagram (https://bit.ly/3g6OYr3), YouTube (https://bit.ly/3zc3up1) and Flicker (https://bit.ly/2Tay0Pu).
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.